⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PDSB News
PDS Biotechnology Corporation Common Stock
PDS Biotech Announces New Composition of Matter Patent for PDS0101 in Japan
globenewswire.com
PDSB
PDS Biotech Announces Scheduling of Type C Meeting with U.S. Food and Drug Administration (“FDA”)
globenewswire.com
PDSB
PDS Biotech Reports Third Quarter 2025 Financial Results and Provides Clinical Programs Update
globenewswire.com
PDSB
PDS Biotechnology Announces up to $11.1 Million Registered Direct Offering
globenewswire.com
PDSB
PDS Biotechnology Announces Translational Data Showing Strong Immunological and Clinical Activity of PDS0101 and PDS01ADC Presented at SITC 2025
globenewswire.com
PDSB
PDS Biotech Announces Conference Call and Webcast for Third Quarter 2025 Financial Results
globenewswire.com
PDSB
New Clinical and Translational Data on PDS Biotechnology’s Novel Investigational Cancer Therapies PDS0101 and PDS01ADC to be Presented at the 2025 Society for Immunotherapy of Cancer (SITC) Annual Meeting
globenewswire.com
PDSB
PDS Biotech to Seek Expedited Approval Pathway for PDS0101 in HPV16-Positive Head and Neck Cancer
globenewswire.com
PDSB